Deeper insight into ferroptosis: association with Alzheimer’s, Parkinson’s disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis

References

• Aw E, Zhang Y, Yalcin E, et al. Chapter two – neuropsychiatric disorders: an immunological perspective. In: Alt FW, Murphy KM, editors. Advances in immunology. Academic Press; 2021. Vol. 152, p. 83–155. doi:10.1016/bs.ai.2021.09.002
   Google Scholar
• Cristino AS, Williams SM, Hawi Z, et al. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry. 2014;19:294–301. doi:10.1038/mp.2013.16
   PubMed Web of Science ®Google Scholar
• Guo X, Lie Q, Liu Y, et al. Multifunctional selenium quantum dots for the treatment of Alzheimer’s disease by reducing Aβ-neurotoxicity and oxidative stress and alleviate neuroinflammation. ACS Appl Mater Interfaces. 2021;13:30261–30273. doi:10.1021/acsami.1c00690
   PubMed Web of Science ®Google Scholar
• Bernardi J, Aromolaran KA, Aromolaran AS. Neurological disorders and risk of arrhythmia. Int J Mol Sci. 2021;22:1–15. doi:10.3390/ijms22010188
   Web of Science ®Google Scholar
• Shan Y, Wang H, Yang Y, et al. Evidence of a large current of transcranial alternating current stimulation directly to deep brain regions. Mol Psychiatry. 2023. doi:10.1038/s41380-023-02150-8
   Web of Science ®Google Scholar
• Lamptey RNL, Chaulagain B, Trivedi R, et al. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022;23. doi:10.3390/ijms23031851
   PubMed Web of Science ®Google Scholar
• Esposito E, Fantin M, Marti M, et al. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res. 2008;25:1521–1530. doi:10.1007/s11095-007-9514-y
   PubMed Web of Science ®Google Scholar
• Nowacek A, Kosloski LM, Gendelman HE. Neurodegenerative disorders and nanoformulated drug development. Nanomedicine. 2009;4:541–555. doi:10.2217/nnm.09.37
   PubMed Web of Science ®Google Scholar
• Basso AS, Frenkel D, Quintana FJ, et al. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest. 2008;118:1532–1543. doi:10.1172/JCI33464
   PubMed Web of Science ®Google Scholar
• Cascione M, De Matteis V, Leporatti S, et al. The new frontiers in neurodegenerative diseases treatment: liposomal-based strategies. Front Bioeng Biotechnol. 2020;8. doi:10.3389/fbioe.2020.566767
   PubMed Web of Science ®Google Scholar
• Kormas P, Moutzouri A. Current psychological approaches in neurodegenerative diseases. In: Vlamos P, Kotsireas IS, Tarnanas I, editors. Handbook of computational neurodegeneration. Cham: Springer International Publishing; 2020. p. 1–29. doi:10.1007/978-3-319-75479-6_10-1
   Google Scholar
• Ahir BK, Engelhard HH, Lakka SS. Tumor development and angiogenesis in adult brain tumor: glioblastoma. Mol Neurobiol. 2020;57:2461–2478. doi:10.1007/s12035-020-01892-8
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang L, Zheng W, et al. Endoscope image mosaic based on pyramid ORB. Biomed Signal Process Control. 2022;71:103261. doi:10.1016/j.bspc.2021.103261
   Web of Science ®Google Scholar
• Reichert CO, de Freitas FA, Sampaio-Silva J, et al. Ferroptosis mechanisms involved in neurodegenerative diseases. Int J Mol Sci. 2020;21:1–27. doi:10.3390/ijms21228765
   Web of Science ®Google Scholar
• Zhang L, Jia R, Li H, et al. Insight into the double-edged role of ferroptosis in disease. Biomolecules. 2021;11:1790. doi:10.3390/biom11121790
   PubMed Web of Science ®Google Scholar
• Cheng Y, Song Y, Chen H, et al. Ferroptosis mediated by lipid reactive oxygen species: a possible causal link of neuroinflammation to neurological disorders. Oxid Med Cell Longev. 2021;2021. doi:10.1155/2021/5005136
   Google Scholar
• Zhou J, Jin Y, Lei Y, et al. Ferroptosis is regulated by mitochondria in neurodegenerative diseases. Neurodegener Dis. 2020;20:20–34. doi:10.1159/000510083
   PubMed Web of Science ®Google Scholar
• Zhang M, Lei Q, Huang X, et al. Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma. Front Pharmacol. 2022;13:1071897.
   PubMedGoogle Scholar
• Potapenko AY, Saparov SM, Agamalieva MA, et al. Fe2 + ions and reduced glutathione – chemical activators of psoralen-sensitized photohaemolysis. J Photochem Photobiol B. 1993;17:69–75. doi:10.1016/1011-1344(93)85009-W
   PubMed Web of Science ®Google Scholar
• Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144–152. doi:10.1016/j.freeradbiomed.2018.09.014
   PubMed Web of Science ®Google Scholar
• Wang Y, Tang B, Zhu J, et al. Emerging mechanisms and targeted therapy of ferroptosis in neurological diseases and neuro-oncology. Int J Biol Sci. 2022;18:4260–4274. doi:10.7150/ijbs.72251
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273–285. doi:10.1016/j.cell.2017.09.021
   PubMed Web of Science ®Google Scholar
• Eaton JK, Furst L, Ruberto RA, et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol. 2020;16:497–506. doi:10.1038/s41589-020-0501-5
   PubMed Web of Science ®Google Scholar
• Cheff DM, Huang C, Scholzen KC, et al. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol. 2023;62:102703. doi:10.1016/j.redox.2023.102703
   PubMed Web of Science ®Google Scholar
• Teng KW, Tsai ST, Hattori T, et al. Selective and noncovalent targeting of RAS mutants for inhibition and degradation. Nat Commun. 2021;12:2656. doi:10.1038/s41467-021-22969-5
   PubMed Web of Science ®Google Scholar
• Fan BY, Pang YL, Li WX, et al. Liproxstatin-1 is an effective inhibitor of oligodendrocyte ferroptosis induced by inhibition of glutathione peroxidase 4. Neural Regen Res. 2021;16:561–566. doi:10.4103/1673-5374.293157
   PubMed Web of Science ®Google Scholar
• Hu W-M, Liu S-Q, Zhu K-F, et al. The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis. Int Immunopharmacol. 2023;121:110505. doi:10.1016/j.intimp.2023.110505
   PubMed Web of Science ®Google Scholar
• Jiang Y, Mao C, Yang R, et al. EGLN1/c-Myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes. Theranostics. 2017;7:3293–3305. doi:10.7150/thno.19988
   PubMed Web of Science ®Google Scholar
• Jiang X, Chen J, Bajić A, et al. Quantitative real-time imaging of glutathione. Nat Commun. 2017;8:16087. doi:10.1038/ncomms16087
   PubMed Web of Science ®Google Scholar
• Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57–62. doi:10.1038/nature14344
   PubMed Web of Science ®Google Scholar
• Tang D, Kroemer G. Ferroptosis. Curr Biol. 2020;30:R1292–R1297. doi:10.1016/j.cub.2020.09.068
   PubMed Web of Science ®Google Scholar
• Liu Y, Gu W. P53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ. 2022;29:895–910. doi:10.1038/s41418-022-00943-y
   PubMed Web of Science ®Google Scholar
• Song Q, Peng S, Che F, et al. Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells. J Pharmacol Sci. 2022;148:300–306. doi:10.1016/j.jphs.2022.01.007
   PubMed Web of Science ®Google Scholar
• Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91–98. doi:10.1038/nchembio.2239
   PubMed Web of Science ®Google Scholar
• Song X, Long D. Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases. Front Neurosci. 2020;14. doi:10.3389/fnins.2020.00267
   Web of Science ®Google Scholar
• Gaschler MM, Andia AA, Liu H, et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018;14:507–515. doi:10.1038/s41589-018-0031-6
   PubMed Web of Science ®Google Scholar
• Li W, Xiang Z, Xing Y, et al. Mitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury. Cell Death Dis. 2022;13:308. doi:10.1038/s41419-022-04770-4
   PubMed Web of Science ®Google Scholar
• Lee J, You JH, Kim M-S, et al. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biol. 2020;37:101697. doi:10.1016/j.redox.2020.101697
   PubMed Web of Science ®Google Scholar
• Zhou B, Liu J, Kang R, et al. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2020;66:89–100. doi:10.1016/j.semcancer.2019.03.002
   PubMed Web of Science ®Google Scholar
• Zille M, Oses-Prieto JA, Savage SR, et al. Hemin-induced death models hemorrhagic stroke and is a variant of classical neuronal ferroptosis. J Neurosci. 2022;42:2065–2079. doi:10.1523/JNEUROSCI.0923-20.2021
   PubMed Web of Science ®Google Scholar
• Yang X-D, Yang Y-Y. Ferroptosis as a novel therapeutic target for diabetes and its complications. Front Endocrinol. 2022;13:853822.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shi J, Liu X, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181–1192. doi:10.1038/s41556-018-0178-0
   PubMed Web of Science ®Google Scholar
• Brown CW, Amante JJ, Mercurio AM. Cell clustering mediated by the adhesion protein PVRL4 is necessary for α6β4 integrin-promoted ferroptosis resistance in matrix-detached cells. J Biol Chem. 2018;293:12741–12748. doi:10.1074/jbc.RA118.003017
   PubMed Web of Science ®Google Scholar
• Vanden BT, Linkermann A, Jouan-Lanhouet S, et al. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014;15:135–147. doi:10.1038/nrm3737
   PubMed Web of Science ®Google Scholar
• Schnapp G, Neubauer H, Büttner FH, et al. A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state. Commun Chem. 2020;3:75. doi:10.1038/s42004-020-0321-2
   PubMed Web of Science ®Google Scholar
• Wu J, Minikes AM, Gao M, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling. Nature. 2019;572:402–406. doi:10.1038/s41586-019-1426-6
   PubMed Web of Science ®Google Scholar
• Dai E, Zhang W, Cong D, et al. AIFM2 blocks ferroptosis independent of ubiquinol metabolism. Biochem Biophys Res Commun. 2020;523:966–971. doi:10.1016/j.bbrc.2020.01.066
   PubMed Web of Science ®Google Scholar
• Poltorack CD, Dixon SJ. Understanding the role of cysteine in ferroptosis: progress & paradoxes. FEBS J. 2022;289:374–385. doi:10.1111/febs.15842
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107–125. doi:10.1038/s41422-020-00441-1
   PubMed Web of Science ®Google Scholar
• Xavier da Silva TN, Schulte C, Alves AN, et al. Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell Death Dis. 2023;14:281. doi:10.1038/s41419-023-05787-z
   PubMed Web of Science ®Google Scholar
• Tang D, Kroemer G. Peroxisome: the new player in ferroptosis. Signal Transduct Target Ther. 2020;5:273. doi:10.1038/s41392-020-00404-3
   PubMed Web of Science ®Google Scholar
• Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6:41–53. doi:10.1021/acscentsci.9b01063
   PubMed Web of Science ®Google Scholar
• Koppula P, Zhuang L, Gan B. Cytochrome P450 reductase (POR) as a ferroptosis fuel. Protein Cell. 2021;12:675–679. doi:10.1007/s13238-021-00823-0
   PubMed Web of Science ®Google Scholar
• Chen X, Xu S, Zhao C, et al. Role of TLR4/NADPH oxidase 4 pathway in promoting cell death through autophagy and ferroptosis during heart failure. Biochem Biophys Res Commun. 2019;516:37–43. doi:10.1016/j.bbrc.2019.06.015
   PubMed Web of Science ®Google Scholar
• Hirata Y, Cai R, Volchuk A, et al. Lipid peroxidation increases membrane tension, piezo1 gating, and cation permeability to execute ferroptosis. Curr Biol. 2023;33:1282–1294.e5. doi:10.1016/j.cub.2023.02.060
   PubMed Web of Science ®Google Scholar
• Zhou S-Y, Cui G-Z, Yan X-L, et al. Mechanism of ferroptosis and its relationships with other types of programmed cell death: insights for potential interventions after intracerebral hemorrhage. Front Neurosci. 2020;14:589042.
   PubMed Web of Science ®Google Scholar
• Lei G, Mao C, Yan Y, et al. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 2021;12:836–857. doi:10.1007/s13238-021-00841-y
   PubMed Web of Science ®Google Scholar
• Procaccianti M, Motta A, Giordani S, et al. First case of typhoid fever due to extensively drug-resistant Salmonella enterica serovar typhi in Italy. Pathogens. 2020;9. doi:10.3390/pathogens9020151
   PubMed Web of Science ®Google Scholar
• Walsh DJ, Bernard DJ, Pangilinan F, et al. Mito-SiPE is a sequence-independent and PCR-free mtDNA enrichment method for accurate ultra-deep mitochondrial sequencing. Commun Biol. 2022;5:1269. doi:10.1038/s42003-022-04182-2
   PubMed Web of Science ®Google Scholar
• Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28:2029–2044. doi:10.1038/s41418-021-00814-y
   PubMed Web of Science ®Google Scholar
• Chen Q, Kang J, Fu C. The independence of and associations among apoptosis, autophagy, and necrosis. Signal Transduct Target Ther. 2018;3:18. doi:10.1038/s41392-018-0018-5
   PubMed Web of Science ®Google Scholar
• Ashraf A, So PW. Spotlight on ferroptosis: iron-dependent cell death in Alzheimer’s disease. Front Aging Neurosci. 2020;12. doi:10.3389/fnagi.2020.00196
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim WK, Bae KH, et al. Lipid metabolism and ferroptosis. Biology. 2021;10:1–16. doi:10.3390/biology10030184
   Google Scholar
• Kuang F, Liu J, Tang D, et al. Oxidative damage and antioxidant defense in ferroptosis. Front Cell Dev Biol. 2020;8. doi:10.3389/fcell.2020.586578
   Web of Science ®Google Scholar
• Capelletti MM, Manceau H, Puy H, et al. Ferroptosis in liver diseases: an overview. Int J Mol Sci. 2020;21:1–23. doi:10.3390/ijms21144908
   Web of Science ®Google Scholar
• Conrad M, Friedmann Angeli JP. Glutathione peroxidase 4 (Gpx4) and ferroptosis: what’s so special about it? Mol Cell Oncol. 2015;2:e995047. doi:10.4161/23723556.2014.995047
   PubMed Web of Science ®Google Scholar
• Chen Y, Fang Z-M, Yi X, et al. The interaction between ferroptosis and inflammatory signaling pathways. Cell Death Dis. 2023;14:205. doi:10.1038/s41419-023-05716-0
   PubMed Web of Science ®Google Scholar
• Yan H, Zou T, Tuo Q, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6:49. doi:10.1038/s41392-020-00428-9
   PubMed Web of Science ®Google Scholar
• Xu S, Li X, Wang Y. Regulation of the p53-mediated ferroptosis signaling pathway in cerebral ischemia stroke (review). Exp Ther Med. 2023;25. doi:10.3892/etm.2023.11812
   Web of Science ®Google Scholar
• Wang H, Guo M, Wei H, et al. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8:92. doi:10.1038/s41392-023-01347-1
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63:173–184.
   PubMed Web of Science ®Google Scholar
• Li FJ, Long HZ, Zhou ZW, et al. System Xc−/GSH/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol. 2022;13. doi:10.3389/fphar.2022.910292
   Web of Science ®Google Scholar
• Liu J, Zhang C, Wang J, et al. The regulation of ferroptosis by tumor suppressor p53 and its pathway. Int J Mol Sci. 2020;21:1–19. doi:10.3390/ijms21218387
   Web of Science ®Google Scholar
• Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19:1800311. doi:10.1002/pmic.201800311
   PubMed Web of Science ®Google Scholar
• Dai E, Zhang W, Cong D, et al. AIFM2 blocks ferroptosis independent of ubiquinol metabolism. Biochem Biophys Res Commun. 2020;523:966–971. doi:10.1016/j.bbrc.2020.01.066
   PubMed Web of Science ®Google Scholar
• Levonen A-L, Lapatto R, Saksela M, et al. Human cystathionine γ-lyase: developmental and in vitro expression of two isoforms. Biochem J. 2000;347:291–295. doi:10.1042/bj3470291
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang Z, Hoshino A, et al. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nat Metab. 2019;1:404–415. doi:10.1038/s42255-019-0043-x
   PubMedGoogle Scholar
• Rižner TL, Penning TM. Role of aldo–keto reductase family 1 (AKR1) enzymes in human steroid metabolism. Steroids. 2014;79:49–63. doi:10.1016/j.steroids.2013.10.012
   PubMed Web of Science ®Google Scholar
• Chowhan RK, Rahaman H, Singh LR. Structural basis of peroxidase catalytic cycle of human Prdx6. Sci Rep. 2020;10:17416. doi:10.1038/s41598-020-74052-6
   PubMed Web of Science ®Google Scholar
• Liao J, Zhang Y, Chen X, et al. The roles of peroxiredoxin 6 in brain diseases. Mol Neurobiol. 2021;58:4348–4364. doi:10.1007/s12035-021-02427-5
   PubMedGoogle Scholar
• Arnér ESJ, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 2000;267:6102–6109. doi:10.1046/j.1432-1327.2000.01701.x
   PubMedGoogle Scholar
• Bjørklund G, Zou L, Wang J, et al. Thioredoxin reductase as a pharmacological target. Pharmacol Res. 2021;174:105854. doi:10.1016/j.phrs.2021.105854
   PubMed Web of Science ®Google Scholar
• Pan L, Gong C, Sun Y, et al. Induction mechanism of ferroptosis: a novel therapeutic target in lung disease. Front Pharmacol. 2022;13:1093244.
   PubMed Web of Science ®Google Scholar
• Frydrych A, Krośniak M, Jurowski K. The role of chosen essential elements (Zn, Cu, Se, Fe, Mn) in food for special medical purposes (FSMPs) dedicated to oncology patients – critical review: state-of-the-art. Nutrients. 2023;15. doi:10.3390/nu15041012
   Web of Science ®Google Scholar
• Lu S, Yang B, Xiao Y, et al. Iterative reconstruction of low-dose CT based on differential sparse. Biomed Signal Process Control. 2023;79:104204. doi:10.1016/j.bspc.2022.104204
   Web of Science ®Google Scholar
• Ni S, Yuan Y, Kuang Y, et al. Iron metabolism and immune regulation. Front Immunol. 2022;13:816282. doi:10.3389/fimmu.2022.816282
   PubMedGoogle Scholar
• Kumar SB, Arnipalli SR, Mehta P, et al. Iron deficiency anemia: efficacy and limitations of nutritional and comprehensive mitigation strategies. Nutrients. 2022;14. doi:10.3390/nu14142976
   Web of Science ®Google Scholar
• Zheng H, Long W, Tan W, et al. Anaemia, iron deficiency, iron-deficiency anaemia and their associations with obesity among schoolchildren in Guangzhou, China. Public Health Nutr. 2020;23:1693–1702. doi:10.1017/S1368980019003604
   PubMed Web of Science ®Google Scholar
• Puig S, Ramos-Alonso L, Romero AM, et al. The elemental role of iron in DNA synthesis and repair. Metallomics. 2017;9:1483–1500. doi:10.1039/c7mt00116a
   PubMed Web of Science ®Google Scholar
• Fernández-García V, González-Ramos S, Martín-Sanz P, et al. Unraveling the interplay between iron homeostasis, ferroptosis and extramedullary hematopoiesis. Pharmacol Res. 2022;183:106386. doi:10.1016/j.phrs.2022.106386
   PubMed Web of Science ®Google Scholar
• Li J, Cao F, Yin H, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88. doi:10.1038/s41419-020-2298-2
   PubMed Web of Science ®Google Scholar
• Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438. doi:10.1155/2014/360438
   PubMed Web of Science ®Google Scholar
• Lei P, Bai T, Sun Y. Mechanisms of ferroptosis and relations with regulated cell death: a review. Front Physiol. 2019;10:139. doi:10.3389/fphys.2019.00139
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107–125. doi:10.1038/s41422-020-00441-1
   PubMed Web of Science ®Google Scholar
• Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2022;289:7038–7050. doi:10.1111/febs.16059
   PubMed Web of Science ®Google Scholar
• Cheng Y, Song Y, Chen H, et al. Ferroptosis mediated by lipid reactive oxygen species: a possible causal link of neuroinflammation to neurological Disorders. Oxid Med Cell Longev. 2021;2021:5005136. doi:10.1155/2021/5005136
   PubMedGoogle Scholar
• Sharma A, Flora SJS. Positive and negative regulation of ferroptosis and its role in maintaining metabolic and redox homeostasis. Oxid Med Cell Longev. 2021;2021:9074206. doi:10.1155/2021/9074206
   PubMed Web of Science ®Google Scholar
• Jyotsana N, Ta KT, DelGiorno KE. The role of cystine/glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer. Front Oncol. 2022;12. doi:10.3389/fonc.2022.858462
   PubMed Web of Science ®Google Scholar
• Fang X, Ardehali H, Min J, et al. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20:7–23. doi:10.1038/s41569-022-00735-4
   PubMed Web of Science ®Google Scholar
• Liu L, Liu R, Liu Y, et al. Cystine-glutamate antiporter xCT as a therapeutic target for cancer. Cell Biochem Funct. 2021;39:174–179. doi:10.1002/cbf.3581
   PubMed Web of Science ®Google Scholar
• Shen L, Lin D, Li X, et al. Ferroptosis in acute central nervous system injuries: the future direction? Front Cell Dev Biol. 2020;8. doi:10.3389/fcell.2020.00594
   Web of Science ®Google Scholar
• Li J, Cao F, Yin H, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88. doi:10.1038/s41419-020-2298-2
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem Biol. 2020;27:365–375. doi:10.1016/j.chembiol.2020.03.013
   PubMed Web of Science ®Google Scholar
• Stepanić V, Kučerová-Chlupáčová M. Review and chemoinformatic analysis of ferroptosis modulators with a focus on natural plant products. Molecules. 2023;28. doi:10.3390/molecules28020475
   Web of Science ®Google Scholar
• Liu L, Wang M, Gong N, et al. Se improves GPX4 expression and SOD activity to alleviate heat-stress-induced ferroptosis-like death in goat mammary epithelial cells. Anim Cells Syst. 2021;25:283–295. doi:10.1080/19768354.2021.1988704
   PubMed Web of Science ®Google Scholar
• Stolwijk JM, Falls-Hubert KC, Searby CC, et al. Simultaneous detection of the enzyme activities of GPx1 and GPx4 guide optimization of selenium in cell biological experiments. Redox Biol. 2020;32:101518. doi:10.1016/j.redox.2020.101518
   PubMed Web of Science ®Google Scholar
• Alim I, Caulfield JT, Chen Y, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell. 2019;177:1262–1279.e25. doi:10.1016/j.cell.2019.03.032
   PubMed Web of Science ®Google Scholar
• Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693–698. doi:10.1038/s41586-019-1707-0
   PubMed Web of Science ®Google Scholar
• Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688–692. doi:10.1038/s41586-019-1705-2
   PubMed Web of Science ®Google Scholar
• Hadian K. Ferroptosis suppressor protein 1 (FSP1) and coenzyme Q10 cooperatively suppress ferroptosis. Biochemistry. 2020;59:637–638. doi:10.1021/acs.biochem.0c00030
   PubMed Web of Science ®Google Scholar
• Li W, Liang L, Liu S, et al. FSP1: a key regulator of ferroptosis. Trends Mol Med. 2023;29:753–764. doi:10.1016/j.molmed.2023.05.013
   PubMed Web of Science ®Google Scholar
• Chen X, Kang R, Kroemer G, et al. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280–296. doi:10.1038/s41571-020-00462-0
   PubMed Web of Science ®Google Scholar
• Kuang G, Wang W, Xiong D, et al. An NADPH sensor that regulates cell ferroptosis. J Transl Med. 2022;20:474. doi:10.1186/s12967-022-03658-3
   PubMed Web of Science ®Google Scholar
• Ding C-KC, Rose J, Sun T, et al. MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nat Metab. 2020;2:270–277. doi:10.1038/s42255-020-0181-1
   PubMedGoogle Scholar
• Li F-J, Long H-Z, Zhou Z-W, et al. System Xc−/GSH/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol. 2022;13:910292.
   PubMed Web of Science ®Google Scholar
• Du Y, Guo Z. Recent progress in ferroptosis: inducers and inhibitors. Cell Death Discov. 2022;8. doi:10.1038/s41420-022-01297-7
   Web of Science ®Google Scholar
• Zhang L, Zhang J, Jin Y, et al. Nrf2 Is a potential modulator for orchestrating iron homeostasis and redox balance in cancer cells. Front Cell Dev Biol. 2021;9:728172.
   PubMed Web of Science ®Google Scholar
• Li F-J, Long H-Z, Zhou Z-W, et al. System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol. 2022;13:910292.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang X, Huang Z, et al. CISD3 inhibition drives cystine-deprivation induced ferroptosis. Cell Death Dis. 2021;12. doi:10.1038/s41419-021-04128-2
   Web of Science ®Google Scholar
• Sun Y, Berleth N, Wu W, et al. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death Dis. 2021;12. doi:10.1038/s41419-021-04306-2
   Web of Science ®Google Scholar
• Wang D, Tang L, Zhang Y, et al. Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis. 2022;13. doi:10.1038/s41419-022-04927-1
   Web of Science ®Google Scholar
• Liu M, Zhu W, Pei D. System Xc−: a key regulatory target of ferroptosis in cancer. Invest New Drugs. 2021;39:1123–1131. doi:10.1007/s10637-021-01070-0
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhuang Y, Liu M, et al. Inhibiting ferroptosis: a novel approach for stroke therapeutics. Drug Discov Today. 2021;26:916–930. doi:10.1016/j.drudis.2020.12.020
   PubMed Web of Science ®Google Scholar
• Sekhar KR, Hanna DN, Cyr S, et al. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer. Sci Rep. 2022;12. doi:10.1038/s41598-022-23906-2
   Web of Science ®Google Scholar
• Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23:369–379. doi:10.1038/cdd.2015.158
   PubMed Web of Science ®Google Scholar
• Riegman M, Sagie L, Galed C, et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture. Nat Cell Biol. 2020;22:1042–1048. doi:10.1038/s41556-020-0565-1
   PubMed Web of Science ®Google Scholar
• Wang P, Lu Y-Q. Ferroptosis: a critical moderator in the life cycle of immune cells. Front Immunol. 2022;13:877634.
   PubMed Web of Science ®Google Scholar
• Brillo V, Chieregato L, Leanza L, et al. Mitochondrial dynamics, ros, and cell signaling: a blended overview. Life. 2021;11. doi:10.3390/life11040332
   PubMedGoogle Scholar
• Chen X, Yu C, Kang R, et al. Iron metabolism in ferroptosis. Front Cell Dev Biol. 2020;8:590226.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu J, Jiang L, et al. Prospects for the role of ferroptosis in fluorosis. Front Physiol. 2021;12:773055.
   PubMed Web of Science ®Google Scholar
• Strocchi S, Reggiani F, Gobbi G, et al. The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation. Oncogene. 2022;41:3665–3679. doi:10.1038/s41388-022-02378-8
   PubMed Web of Science ®Google Scholar
• Mashima R, Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol. 2015;6:297–310. doi:10.1016/j.redox.2015.08.006
   PubMed Web of Science ®Google Scholar
• Yan H, Zou T, Tuo Q, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6:49. doi:10.1038/s41392-020-00428-9
   PubMed Web of Science ®Google Scholar
• Yu Y, Yan Y, Niu F, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021;7:193. doi:10.1038/s41420-021-00579-w
   PubMed Web of Science ®Google Scholar
• Barayeu U, Schilling D, Eid M, et al. Hydropersulfides inhibit lipid peroxidation and ferroptosis by scavenging radicals. Nat Chem Biol. 2023;19:28–37. doi:10.1038/s41589-022-01145-w
   PubMed Web of Science ®Google Scholar
• Sokoła-Wysoczańska E, Wysoczański T, Wagner J, et al. Polyunsaturated fatty acids and their potential therapeutic role in cardiovascular system disorders – a review. Nutrients. 2018;10. doi:10.3390/nu10101561
   PubMed Web of Science ®Google Scholar
• Schwingshackl L, Hoffmann G. Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients. 2012;4:1989–2007. doi:10.3390/nu4121989
   PubMed Web of Science ®Google Scholar
• Xie LH, Fefelova N, Pamarthi SH, et al. Molecular mechanisms of ferroptosis and relevance to cardiovascular disease. Cells. 2022;11:2726. doi:10.3390/cells11172726
   PubMed Web of Science ®Google Scholar
• Chen J, Yang L, Geng L, et al. Inhibition of acyl-CoA synthetase long-chain family member 4 facilitates neurological recovery after stroke by regulation ferroptosis. Front Cell Neurosci. 2021;15:632354.
   PubMed Web of Science ®Google Scholar
• Danielli M, Perne L, Jarc Jovičić E, et al. Lipid droplets and polyunsaturated fatty acid trafficking: balancing life and death. Front Cell Dev Biol. 2023;11. doi:10.3389/fcell.2023.1104725
   PubMed Web of Science ®Google Scholar
• Xiao L, Huang H, Fan S, et al. Ferroptosis: a mixed blessing for infectious diseases. Front Pharmacol. 2022;13:992734.
   PubMed Web of Science ®Google Scholar
• Dang Q, Sun Z, Wang Y, et al. Ferroptosis: a double-edged sword mediating immune tolerance of cancer. Cell Death Dis. 2022;13:925. doi:10.1038/s41419-022-05384-6
   PubMed Web of Science ®Google Scholar
• Lu S, Liu S, Hou P, et al. Soft tissue feature tracking based on deep matching network. CMES Comput Model Eng Sci. 2023;136:363–379. doi:10.32604/cmes.2023.025217
   Web of Science ®Google Scholar
• Schaur RJ, Siems W, Bresgen N, et al. 4-hydroxy-nonenal – a bioactive lipid peroxidation product. Biomolecules. 2015;5:2247–2337. doi:10.3390/biom5042247
   PubMed Web of Science ®Google Scholar
• Murao A, Aziz M, Wang H, et al. Release mechanisms of major DAMPs. Apoptosis. 2021;26:152–162. doi:10.1007/s10495-021-01663-3
   PubMed Web of Science ®Google Scholar
• Chen X, Comish PB, Tang D, et al. Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol. 2021;9. doi:10.3389/fcell.2021.637162
   Web of Science ®Google Scholar
• Shi J, Lai D, Zuo X, et al. Identification of ferroptosis-related biomarkers for prognosis and immunotherapy in patients with glioma. Front Cell Dev Biol. 2022;10:817643.
   PubMed Web of Science ®Google Scholar
• Feng Z, Qin Y, Huo F, et al. NMN recruits GSH to enhance GPX4-mediated ferroptosis defense in UV irradiation induced skin injury. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166287. doi:10.1016/j.bbadis.2021.166287
   PubMed Web of Science ®Google Scholar
• Otasevic V, Vucetic M, Grigorov I, et al. Ferroptosis in different pathological contexts seen through the eyes of mitochondria. Oxid Med Cell Longev. 2021;2021:5537330. doi:10.1155/2021/5537330
   PubMed Web of Science ®Google Scholar
• Oh S-J, Ikeda M, Ide T, et al. Mitochondrial event as an ultimate step in ferroptosis. Cell Death Discov. 2022;8:414. doi:10.1038/s41420-022-01199-8
   PubMed Web of Science ®Google Scholar
• Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266–282. doi:10.1038/s41580-020-00324-8
   PubMed Web of Science ®Google Scholar
• Bi Q, Sun Z, Wu J, et al. Ferroptosis-mediated formation of tumor-promoting immune microenvironment. Front Oncol. 2022;12:868639.
   PubMed Web of Science ®Google Scholar
• Palla G, Fischer DS, Regev A, et al. Spatial components of molecular tissue biology. Nat Biotechnol. 2022;40:308–318. doi:10.1038/s41587-021-01182-1
   PubMed Web of Science ®Google Scholar
• Zhang C-R, Fan C-Q, Zhang L, et al. Chuktabrins A and B, two novel limonoids from the twigs and leaves of Chukrasia tabularis. Org Lett. 2008;10:3183–3186. doi:10.1021/ol800885h
   PubMed Web of Science ®Google Scholar
• Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81–90. doi:10.1038/nchembio.2238
   PubMed Web of Science ®Google Scholar
• Weigand I, Schreiner J, Röhrig F, et al. Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction. Cell Death Dis. 2020;11. doi:10.1038/s41419-020-2385-4
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Pissas G, Antoniadi G, et al. Cell death patterns due to warm ischemia or reperfusion in renal tubular epithelial cells originating from human, mouse, or the native hibernator hamster. Biology. 2018;7. doi:10.3390/biology7040048
   PubMedGoogle Scholar
• Wang Y, Chen Q, Shi C, et al. Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress. Mol Med Rep. 2019;20:4081–4090. doi:10.3892/mmr.2019.10660
   PubMed Web of Science ®Google Scholar
• Ma L, Jiang F, Fan X, et al. Metal–organic-framework-engineered enzyme-mimetic catalysts. Adv Mater. 2020;32:2003065. doi:10.1002/adma.202003065
   Web of Science ®Google Scholar
• Tang X, Hu W, You W, et al. Exploration of key ferroptosis-related genes and immune infiltration in Crohn’s disease using bioinformatics. Sci Rep. 2023;13:12769. doi:10.1038/s41598-023-40093-w
   PubMed Web of Science ®Google Scholar
• Boutros M, Ahringer J. The art and design of genetic screens: RNA interference. Nat Rev Genet. 2008;9:554–566. doi:10.1038/nrg2364
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26:1021–1032. doi:10.1038/cr.2016.95
   PubMed Web of Science ®Google Scholar
• Cao JY, Poddar A, Magtanong L, et al. A genome-wide haploid genetic screen identifies regulators of glutathione abundance and ferroptosis sensitivity. Cell Rep. 2019;26:1544–1556.e8. doi:10.1016/j.celrep.2019.01.043
   PubMed Web of Science ®Google Scholar
• Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12. doi:10.1186/s13045-019-0720-y
   PubMed Web of Science ®Google Scholar
• Pepper SE, Borkowski M, Richmann MK, et al. Determination of ferrous and ferric iron in aqueous biological solutions. Anal Chim Acta. 2010;663:172–177. doi:10.1016/j.aca.2010.01.056
   PubMed Web of Science ®Google Scholar
• Nan X, Huyan Y, Li H, et al. Reaction-based fluorescent probes for Hg2+, Cu2 + and Fe3+/Fe2 +. Coord Chem Rev. 2021;426:213580. doi:10.1016/j.ccr.2020.213580
   Web of Science ®Google Scholar
• Reynard B, Fellah C, McCammon C. Iron oxidation state in serpentines and magnesian chlorites of subduction-related rocks. Eur J Mineral. 2022;34:645–656. doi:10.5194/ejm-34-645-2022
   Web of Science ®Google Scholar
• Zhang X, Ma G, Wei W. Simulation of nanoparticles interacting with a cell membrane: probing the structural basis and potential biomedical application. NPG Asia Mater. 2021;13:52. doi:10.1038/s41427-021-00320-0
   Web of Science ®Google Scholar
• Abdelkhalek A, El-Latif MA, Ibrahim H, et al. Controlled synthesis of graphene oxide/silica hybrid nanocomposites for removal of aromatic pollutants in water. Sci Rep. 2022;12:7060. doi:10.1038/s41598-022-10602-4
   PubMed Web of Science ®Google Scholar
• Herbison CE, Thorstensen K, Chua ACG, et al. The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells. Am J Physiol Cell Physiol. 2009;297:C1567–C1575. doi:10.1152/ajpcell.00649.2008
   PubMed Web of Science ®Google Scholar
• Sun X, Fan J, Fu C, et al. WS2 and MoS2 biosensing platforms using peptides as probe biomolecules. Sci Rep. 2017;7:10290. doi:10.1038/s41598-017-10221-4
   PubMed Web of Science ®Google Scholar
• Chen T, Zou H, Wu X, et al. Nanozymatic antioxidant system based on MoS2 nanosheets. ACS Appl Mater Interfaces. 2018;10:12453–12462. doi:10.1021/acsami.8b01245
   PubMed Web of Science ®Google Scholar
• Wang F, Gómez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic. 2018;19:918–931. doi:10.1111/tra.12613
   PubMed Web of Science ®Google Scholar
• Li A, Gao M, Liu B, et al. Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease. Cell Death Dis. 2022;13:444. doi:10.1038/s41419-022-04906-6
   PubMed Web of Science ®Google Scholar
• Gao M, Yi J, Zhu J, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73:354–363.e3. doi:10.1016/j.molcel.2018.10.042
   PubMed Web of Science ®Google Scholar
• Zhang D, Cui P, Dai Z, et al. Tumor microenvironment responsive FePt/MoS2 nanocomposites with chemotherapy and photothermal therapy for enhancing cancer immunotherapy. Nanoscale. 2019;11:19912–19922. doi:10.1039/C9NR05684J
   PubMed Web of Science ®Google Scholar
• Huang K-J, Wei Y-H, Chiu Y-C, et al. Assessment of zero-valent iron-based nanotherapeutics for ferroptosis induction and resensitization strategy in cancer cells. Biomater Sci. 2019;7:1311–1322. doi:10.1039/C8BM01525B
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu Z, Zhang Y, et al. ‘Iron free’ zinc oxide nanoparticles with ion-leaking properties disrupt intracellular ROS and iron homeostasis to induce ferroptosis. Cell Death Dis. 2020;11. doi:10.1038/s41419-020-2384-5
   Web of Science ®Google Scholar
• Ren J-X, Sun X, Yan X-L, et al. Ferroptosis in neurological diseases. Front Cell Neurosci. 2020;14:218.
   PubMed Web of Science ®Google Scholar
• Kwok JC, Richardson DR. The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hematol. 2002;42:65–78. doi:10.1016/S1040-8428(01)00213-X
   PubMed Web of Science ®Google Scholar
• Hassannia B, Wiernicki B, Ingold I, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Invest. 2018;128:3341–3355. doi:10.1172/JCI99032
   PubMed Web of Science ®Google Scholar
• Xu Y, Qin Z, Ma J, et al. Recent progress in nanotechnology based ferroptotic therapies for clinical applications. Eur J Pharmacol. 2020;880. doi:10.1016/j.ejphar.2020.173198
   Web of Science ®Google Scholar
• Zhang Y, Tan H, Daniels JD, et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biol. 2019;26:623–633.e9. doi:10.1016/j.chembiol.2019.01.008
   PubMed Web of Science ®Google Scholar
• Ma P, Xiao H, Yu C, et al. Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species. Nano Lett. 2017;17:928–937. doi:10.1021/acs.nanolett.6b04269
   PubMed Web of Science ®Google Scholar
• Cascione M, De Matteis V, Leporatti S, et al. The new frontiers in neurodegenerative diseases treatment: liposomal-based strategies. Front Bioeng Biotechnol. 2020;8. doi:10.3389/fbioe.2020.566767
   PubMed Web of Science ®Google Scholar
• Wu J, Wang Y, Jiang R, et al. Ferroptosis in liver disease: new insights into disease mechanisms. Cell Death Discov. 2021;7:276. doi:10.1038/s41420-021-00660-4
   PubMed Web of Science ®Google Scholar
• Durães F, Pinto M, Sousa E. Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals. 2018;11. doi:10.3390/ph11020044
   Web of Science ®Google Scholar
• Akhtar A, Andleeb A, Waris TS, et al. Neurodegenerative diseases and effective drug delivery: a review of challenges and novel therapeutics. J Controlled Release. 2021;330:1152–1167. doi:10.1016/j.jconrel.2020.11.021
   PubMed Web of Science ®Google Scholar
• Ou M, Jiang Y, Ji Y, et al. Role and mechanism of ferroptosis in neurological diseases. Mol Metab. 2022;61. doi:10.1016/j.molmet.2022.101502
   PubMed Web of Science ®Google Scholar
• Norat P, Soldozy S, Sokolowski JD, et al. Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation. NPJ Regen Med. 2020;5:22. doi:10.1038/s41536-020-00107-x
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A. Preventing neurodegenerative disease. Brain. 2021;144:1279–1280. doi:10.1093/brain/awab151
   PubMed Web of Science ®Google Scholar
• Sheikh S, Haque E, Mir SS. Neurodegenerative diseases: multifactorial conformational diseases and their therapeutic interventions. J Neurodegener Dis. 2013;2013:563481. doi:10.1155/2013/563481
   PubMedGoogle Scholar
• Gan L, Cookson MR, Petrucelli L, et al. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci. 2018;21:1300–1309. doi:10.1038/s41593-018-0237-7
   PubMed Web of Science ®Google Scholar
• Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9. doi:10.1101/cshperspect.a028035
   Web of Science ®Google Scholar
• Davenport F, Gallacher J, Kourtzi Z, et al. Neurodegenerative disease of the brain: a survey of interdisciplinary approaches. J R Soc Interface. 2023;20. doi:10.1098/rsif.2022.0406
   PubMed Web of Science ®Google Scholar
• Zheng H, Jiang J, Xu S, et al. Nanoparticle-induced ferroptosis: detection methods, mechanisms and applications. Nanoscale. 2021;13:2266–2285. doi:10.1039/d0nr08478f
   PubMed Web of Science ®Google Scholar
• Sheikh S, Haque E, Mir SS. Neurodegenerative diseases: multifactorial conformational diseases and their therapeutic interventions. J Neurodegener Dis. 2013;2013:563481. doi:10.1155/2013/563481
   PubMedGoogle Scholar
• Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7:33. doi:10.1038/s41572-021-00269-y
   PubMed Web of Science ®Google Scholar
• Li X, Feng X, Sun X, et al. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2019. Front Aging Neurosci. 2022;14:937486.
   PubMed Web of Science ®Google Scholar
• Zhang J, Shen Q, Ma Y, et al. Calcium homeostasis in Parkinson’s disease: from pathology to treatment. Neurosci Bull. 2022;38:1267–1270. doi:10.1007/s12264-022-00899-6
   PubMed Web of Science ®Google Scholar
• Zhang K, Yang Y, Ge H, et al. Neurogenesis and proliferation of neural stem/progenitor cells conferred by artesunate via FOXO3a/p27Kip1 axis in mouse stroke model. Mol Neurobiol. 2022;59:4718–4729. doi:10.1007/s12035-021-02710-5
   PubMed Web of Science ®Google Scholar
• Rahman MM, Lendel C. Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology. Mol Neurodegener. 2021;16:59. doi:10.1186/s13024-021-00465-0
   PubMed Web of Science ®Google Scholar
• Bellenguez C, Küçükali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. 2022;54:412–436. doi:10.1038/s41588-022-01024-z
   PubMed Web of Science ®Google Scholar
• Wang H, Wang K, Xue Q, et al. Transcranial alternating current stimulation for treating depression: a randomized controlled trial. Brain. 2022;145:83–91. doi:10.1093/brain/awab252
   PubMed Web of Science ®Google Scholar
• Abubakar MB, Sanusi KO, Ugusman A, et al. Alzheimer’s disease: an update and insights into pathophysiology. Front Aging Neurosci. 2022;14. doi:10.3389/fnagi.2022.742408
   PubMed Web of Science ®Google Scholar
• Gauvrit T, Benderradji H, Buée L, et al. Early-life environment influence on late-onset Alzheimer’s disease. Front Cell Dev Biol. 2022;10. doi:10.3389/fcell.2022.834661
   PubMed Web of Science ®Google Scholar
• Tahami Monfared AA, Byrnes MJ, White LA, et al. Alzheimer’s disease: epidemiology and clinical progression. Neurol Ther. 2022;11:553–569. doi:10.1007/s40120-022-00338-8
   PubMed Web of Science ®Google Scholar
• Breijyeh Z, Karaman R. Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules. 2020;25. doi:10.3390/MOLECULES25245789
   Web of Science ®Google Scholar
• König T, Stögmann E. Genetics of Alzheimer’s disease. Wien Med Wochenschr. 2021;171:249–256. doi:10.1007/s10354-021-00819-9
   PubMed Web of Science ®Google Scholar
• Bateman RJ, Xiong C, Benzinger TLS, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804. doi:10.1056/nejmoa1202753
   PubMed Web of Science ®Google Scholar
• Jagaran K, Singh M. Nanomedicine for neurodegenerative disorders: focus on Alzheimer’s and Parkinson’s diseases. Int J Mol Sci. 2021;22. doi:10.3390/ijms22169082
   PubMed Web of Science ®Google Scholar
• Guo T, Zhang D, Zeng Y, et al. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener. 2020;15. doi:10.1186/s13024-020-00391-7
   Web of Science ®Google Scholar
• Eitan E, Hutchison ER, Marosi K, et al. Extracellular vesicle-associated aβ mediates trans-neuronal bioenergetic and ca2+-handling deficits in Alzheimer’s disease models. NPJ Aging Mech Dis. 2016;2. doi:10.1038/npjamd.2016.19
   PubMedGoogle Scholar
• Zhang M, Mao X, Yu Y, et al. Nanomaterials for reducing amyloid cytotoxicity. Adv Mater. 2013;25:3780–3801. doi:10.1002/adma.201301210
   PubMed Web of Science ®Google Scholar
• Chen K, Jiang X, Wu M, et al. Ferroptosis, a potential therapeutic target in Alzheimer’s disease. Front Cell Dev Biol. 2021;9:704298.
   PubMed Web of Science ®Google Scholar
• Di Domenico F, Tramutola A, Butterfield DA. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic Biol Med. 2017;111:253–261. doi:10.1016/j.freeradbiomed.2016.10.490
   PubMed Web of Science ®Google Scholar
• Peña-Bautista C, Baquero M, Vento M, et al. Free radicals in Alzheimer’s disease: lipid peroxidation biomarkers. Clin Chim Acta. 2019;491:85–90. doi:10.1016/j.cca.2019.01.021
   PubMed Web of Science ®Google Scholar
• Zhang C, Rodriguez C, Spaulding J, et al. Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer’s disease. J Alzheimer’s Dis. 2012;28:655–666. doi:10.3233/JAD-2011-111244
   PubMed Web of Science ®Google Scholar
• He L, He T, Farrar S, et al. Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell Physiol Biochem. 2017;44:532–553. doi:10.1159/000485089
   PubMed Web of Science ®Google Scholar
• Corey-Bloom J. The ABC of Alzheimer’s disease: cognitive changes and their management in Alzheimer’s disease and related dementias. Int Psychogeriatr. 2002;14:51–75. doi:10.1017/S1041610203008664
   PubMed Web of Science ®Google Scholar
• Tu J, Yan J, Liu J, et al. Iron deposition in the precuneus is correlated with mild cognitive impairment in patients with cerebral microbleeds: a quantitative susceptibility mapping study. Front Neurosci. 2022;16:944709.
   PubMed Web of Science ®Google Scholar
• Hampel H, Hardy J, Blennow K, et al. The amyloid-β pathway in Alzheimer’s disease. Mol Psychiatry. 2021;26:5481–5503. doi:10.1038/s41380-021-01249-0
   PubMed Web of Science ®Google Scholar
• Wang F, Wang J, Shen Y, et al. Iron dyshomeostasis and ferroptosis: a new Alzheimer’s disease hypothesis? Front Aging Neurosci. 2022;14:830569.
   PubMed Web of Science ®Google Scholar
• Yan N, Zhang J. Iron metabolism, ferroptosis, and the links with Alzheimer’s disease. Front Neurosci. 2020;13:1443.
   PubMedGoogle Scholar
• Ou M, Jiang Y, Ji Y, et al. Role and mechanism of ferroptosis in neurological diseases. Mol Metab. 2022;61:101502. doi:10.1016/j.molmet.2022.101502
   PubMed Web of Science ®Google Scholar
• Honarpisheh P, Reynolds CR, Conesa MPB, et al. Dysregulated gut homeostasis observed prior to the accumulation of the brain amyloid-β in Tg2576 mice. Int J Mol Sci. 2020;21. doi:10.3390/ijms21051711
   PubMed Web of Science ®Google Scholar
• Lee S, Yang M, Kim J, et al. Trimethyltin-induced hippocampal neurodegeneration: a mechanism-based review. Brain Res Bull. 2016;125:187–199. doi:10.1016/j.brainresbull.2016.07.010
   PubMed Web of Science ®Google Scholar
• Chuprin J, Buettner H, Seedhom MO, et al. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol. 2023;20:192–206. doi:10.1038/s41571-022-00721-2
   PubMed Web of Science ®Google Scholar
• Porsteinsson AP, Isaacson RS, Knox S, et al. Diagnosis of early Alzheimer’s disease: clinical practice in 2021. J Prev Alzheimer’s Dis. 2021;8:371–386. doi:10.14283/jpad.2021.23
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang Q, Tian J-H, et al. Perfluorocarbon-based nanomedicine: emerging strategy for diagnosis and treatment of diseases. MRS Commun. 2018;8:303–313. doi:10.1557/mrc.2018.49
   Web of Science ®Google Scholar
• Zhang G, Yuan C, Sun Y. Effect of selective encapsulation of hydroxypropyl-β-cyclodextrin on components and antibacterial properties of star anise essential oil. Molecules. 2018;23. doi:10.3390/molecules23051126
   Web of Science ®Google Scholar
• Fernández-Bertólez N, Costa C, Bessa MJ, et al. Assessment of oxidative damage induced by iron oxide nanoparticles on different nervous system cells. Mutat Res/Genet Toxicol Environ Mutagen. 2019;845:402989. doi:10.1016/j.mrgentox.2018.11.013
   PubMed Web of Science ®Google Scholar
• Morris G, Berk M, Carvalho AF, et al. Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases. Behav Brain Res. 2018;341:154–175. doi:10.1016/j.bbr.2017.12.036
   PubMed Web of Science ®Google Scholar
• Maher P. Potentiation of glutathione loss and nerve cell death by the transition metals iron and copper: implications for age-related neurodegenerative diseases. Free Radic Biol Med. 2018;115:92–104. doi:10.1016/j.freeradbiomed.2017.11.015
   PubMed Web of Science ®Google Scholar
• Hirata Y, Yamada C, Ito Y, et al. Novel oxindole derivatives prevent oxidative stress-induced cell death in mouse hippocampal HT22 cells. Neuropharmacology. 2018;135:242–252. doi:10.1016/j.neuropharm.2018.03.015
   PubMed Web of Science ®Google Scholar
• Wang J, Wang F, Mai D, et al. Molecular mechanisms of glutamate toxicity in Parkinson’s disease. Front Neurosci. 2020;14:585584.
   PubMed Web of Science ®Google Scholar
• Simões AP, Silva CG, Marques JM, et al. Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation. Cell Death Dis. 2018;9:297. doi:10.1038/s41419-018-0351-1
   PubMed Web of Science ®Google Scholar
• Kostandy BB. The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci. 2012;33:223–237. doi:10.1007/s10072-011-0828-5
   PubMed Web of Science ®Google Scholar
• Yagami T, Yamamoto Y, Koma H. Pathophysiological roles of intracellular proteases in neuronal development and neurological diseases. Mol Neurobiol. 2019;56:3090–3112. doi:10.1007/s12035-018-1277-4
   PubMed Web of Science ®Google Scholar
• Fischer W, Currais A, Liang Z, et al. Old age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa. Redox Biol. 2019;21:101089. doi:10.1016/j.redox.2018.101089
   PubMed Web of Science ®Google Scholar
• Gunesch S, Hoffmann M, Kiermeier C, et al. 7-O-esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo. Redox Biol. 2020;29:101378. doi:10.1016/j.redox.2019.101378
   PubMed Web of Science ®Google Scholar
• Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093. doi:10.1126/science.1104742
   PubMed Web of Science ®Google Scholar
• Cong L, Dong X, Wang Y, et al. On the role of synthesized hydroxylated chalcones as dual functional amyloid-β aggregation and ferroptosis inhibitors for potential treatment of Alzheimer’s disease. Eur J Med Chem. 2019;166:11–21. doi:10.1016/j.ejmech.2019.01.039
   PubMed Web of Science ®Google Scholar
• Ates G, Goldberg J, Currais A, et al. CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer’s disease. Redox Biol. 2020;36:101648. doi:10.1016/j.redox.2020.101648
   PubMed Web of Science ®Google Scholar
• Wang L, Cao Y, Tang Q, et al. Role of the blood-brain barrier in rabies virus infection and protection. Protein Cell. 2013;4:901–903. doi:10.1007/s13238-013-3918-8
   PubMed Web of Science ®Google Scholar
• Hao R, Sun B, Yang L, et al. RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery. Drug Deliv. 2020;27:772–781. doi:10.1080/10717544.2020.1760960
   PubMed Web of Science ®Google Scholar
• Dong K, Wang Z, Zhang Y, et al. Metal–organic framework-based nanoplatform for intracellular environment-responsive endo/lysosomal escape and enhanced cancer therapy. ACS Appl Mater Interfaces. 2018;10:31998–32005. doi:10.1021/acsami.8b11972
   PubMed Web of Science ®Google Scholar
• Tansey MG, Wallings RL, Houser MC, et al. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657–673. doi:10.1038/s41577-022-00684-6
   PubMed Web of Science ®Google Scholar
• Chen F, Chen S, Si A, et al. The long-term trend of Parkinson’s disease incidence and mortality in China and a Bayesian projection from 2020 to 2030. Front Aging Neurosci. 2022;14:973310.
   PubMed Web of Science ®Google Scholar
• Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7:47. doi:10.1038/s41572-021-00280-3
   PubMed Web of Science ®Google Scholar
• Ou Z, Pan J, Tang S, et al. Global trends in the incidence, prevalence, and years lived with disability of Parkinson’s disease in 204 countries/territories from 1990 to 2019. Front Public Health. 2021;9:776847.
   PubMed Web of Science ®Google Scholar
• Mesman S, Smidt MP. Acquisition of the midbrain dopaminergic neuronal identity. Int J Mol Sci. 2020;21:1–20. doi:10.3390/ijms21134638
   Web of Science ®Google Scholar
• Carmichael K, Sullivan B, Lopez E, et al. Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease. Ageing Neurodegener Dis. 2021. doi:10.20517/and.2021.07
   PubMedGoogle Scholar
• Aman Y. Selective loss among dopaminergic neurons in Parkinson’s disease. Nat Aging. 2022;2:462. doi:10.1038/s43587-022-00242-8
   Google Scholar
• Wu L, Liu M, Liang J, et al. Ferroptosis as a new mechanism in Parkinson’s disease therapy using traditional Chinese medicine. Front Pharmacol. 2021;12:659584.
   PubMed Web of Science ®Google Scholar
• Mobarra N, Shanaki M, Ehteram H, et al. A review on iron chelators in treatment of iron overload syndromes. Int J Hematol Oncol Stem Cell Res. 2016;10:239.
   PubMedGoogle Scholar
• Feng G, Zhang Z, Bao Q, et al. Protective effect of chinonin in MPTP-induced C57BL/6 mouse model of Parkinson’s disease. Pharm Bull. 2014;37(8):1301–1307. doi:10.1248/bpb.b14-00128
   Google Scholar
• Takahashi S, Hisatsune A, Kurauchi Y, et al. Polysulfide protects midbrain dopaminergic neurons from MPP+-induced degeneration via enhancement of glutathione biosynthesis. J Pharmacol Sci. 2018;137:47–54. doi:10.1016/j.jphs.2018.04.004
   PubMed Web of Science ®Google Scholar
• Everett J, Brooks J, Lermyte F, et al. Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42). Sci Rep. 2020;10:10332. doi:10.1038/s41598-020-67117-z
   PubMed Web of Science ®Google Scholar
• Tian Y, Lu J, Hao X, et al. FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson’s disease. Neurotherapeutics. 2020;17:1796–1812. doi:10.1007/s13311-020-00929-z
   PubMed Web of Science ®Google Scholar
• Zhang P, Chen L, Zhao Q, et al. Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson’s disease. Free Radic Biol Med. 2020;152:227–234. doi:10.1016/j.freeradbiomed.2020.03.015
   PubMed Web of Science ®Google Scholar
• Monge-Fuentes V, Biolchi Mayer A, Lima MR, et al. Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s disease. Sci Rep. 2021;11:15185. doi:10.1038/s41598-021-94175-8
   PubMed Web of Science ®Google Scholar
• Tryphena KP, Singh G, Jain N, et al. Integration of miRNA’s theranostic potential with nanotechnology: promises and challenges for Parkinson’s disease therapeutics. Mech Ageing Dev. 2023;211:111800. doi:10.1016/j.mad.2023.111800
   PubMed Web of Science ®Google Scholar
• Booth R, Kim H. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). Lab Chip. 2012;12:1784–1792. doi:10.1039/C2LC40094D
   PubMed Web of Science ®Google Scholar
• Guo X, Shi Y, Liu D, et al. Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors. Front Oncol. 2023;13:1131642.
   PubMed Web of Science ®Google Scholar
• Rong L, Li N, Zhang Z. Emerging therapies for glioblastoma: current state and future directions. J Exp Clin Cancer Res. 2022;41:142. doi:10.1186/s13046-022-02349-7
   PubMed Web of Science ®Google Scholar
• Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329:574–587. doi:10.1001/jama.2023.0023
   PubMed Web of Science ®Google Scholar
• Moschetta M, Trevisani M, Castagnola V, et al. Chapter 19 – nanotechnology-based approaches in glioblastoma treatment: how can the dual blood-brain/tumor barriers be overcome? In: Vitorino C, Balaña C, Cabral C, editors. New insights into glioblastoma. Academic Press; 2023. p. 435–475. doi:10.1016/B978-0-323-99873-4.00020-7
   Google Scholar
• Wu W, Klockow JL, Zhang M, et al. Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021;171:105780. doi:10.1016/j.phrs.2021.105780
   PubMed Web of Science ®Google Scholar
• Oishi T, Koizumi S, Kurozumi K. Molecular mechanisms and clinical challenges of glioma invasion. Brain Sci. 2022;12. doi:10.3390/brainsci12020291
   PubMed Web of Science ®Google Scholar
• An Z, Aksoy O, Zheng T, et al. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene. 2018;37:1561–1575. doi:10.1038/s41388-017-0045-7
   PubMed Web of Science ®Google Scholar
• Keller S, Schmidt MHH. EGFR and EGFRvIII promote angiogenesis and cell invasion in glioblastoma: combination therapies for an effective treatment. Int J Mol Sci. 2017;18. doi:10.3390/ijms18061295
   PubMed Web of Science ®Google Scholar
• Banerjee K, Núñez FJ, Haase S, et al. Current approaches for glioma gene therapy and virotherapy. Front Mol Neurosci. 2021;14. doi:10.3389/fnmol.2021.621831
   PubMed Web of Science ®Google Scholar
• Li R, Wang H, Liang Q, et al. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies. Biomater Sci. 2022;10:892–908. doi:10.1039/D1BM01401C
   PubMed Web of Science ®Google Scholar
• Miretti M, González Graglia MA, Suárez AI, et al. Photodynamic therapy for glioblastoma: a light at the end of the tunnel. J Photochem Photobiol. 2023;13:100161. doi:10.1016/j.jpap.2023.100161
   Google Scholar
• Liu S, Shi W, Zhao Q, et al. Progress and prospect in tumor treating fields treatment of glioblastoma. Biomed Pharmacother. 2021;141:111810. doi:10.1016/j.biopha.2021.111810
   PubMed Web of Science ®Google Scholar
• Slavkov D, Hadzhiyanev A, Slavkova S. Tumor treating fields: a new treatment for glioblastoma. Biotechnol Biotechnol Equip. 2023;37:58–63. doi:10.1080/13102818.2022.2155567
   Web of Science ®Google Scholar
• Yasinjan F, Xing Y, Geng H, et al. Immunotherapy: a promising approach for glioma treatment. Front Immunol. 2023;14. doi:10.3389/fimmu.2023.1255611
   Web of Science ®Google Scholar
• Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560–575. doi:10.1038/s41580-023-00585-z
   PubMed Web of Science ®Google Scholar
• Liu Y, Lei H, Zhang W, et al. Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance. Cell Death Dis. 2023;14:472. doi:10.1038/s41419-023-06005-6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fu X, Jia J, et al. Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles. ACS Appl Mater Interfaces. 2020;12:43408–43421. doi:10.1021/acsami.0c12042
   PubMed Web of Science ®Google Scholar
• Zhou L, Liu Y, Sun H, et al. Usefulness of enzyme-free and enzyme-resistant detection of complement component 5 to evaluate acute myocardial infarction. Sens Actuators B Chem. 2022;369:132315. doi:10.1016/j.snb.2022.132315
   Web of Science ®Google Scholar
• Hao P, Li H, Zhou L, et al. Serum metal Ion-induced cross-linking of photoelectrochemical peptides and circulating proteins for evaluating cardiac ischemia/reperfusion. ACS Sens. 2022;7:775–783. doi:10.1021/acssensors.1c02305
   PubMed Web of Science ®Google Scholar
• Wang X, Zhu K, Zhang L, et al. Preparation of high-quality glass-ceramics entirely derived from fly ash of municipal solid waste incineration and coal enhanced with pressure pretreatment. J Clean Prod. 2021;324:129021. doi:10.1016/j.jclepro.2021.129021
   Web of Science ®Google Scholar
• Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20:689–709. doi:10.1038/s41573-021-00233-1
   PubMed Web of Science ®Google Scholar
• Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280–297. doi:10.1038/s41568-021-00435-0
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang F, Zhai W, et al. Unraveling of advances in 3D-printed polymer-based bone scaffolds. Polymers. 2022;14. doi:10.3390/polym14030566
   Web of Science ®Google Scholar
• Zhao L-X, Gong Z-Q, Zhang Q, et al. Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma. J Controlled Release. 2023;359:12–25. doi:10.1016/j.jconrel.2023.05.035
   PubMed Web of Science ®Google Scholar
• Chi H, Li B, Wang Q, et al. Opportunities and challenges related to ferroptosis in glioma and neuroblastoma. Front Oncol. 2023;13:1065994.
   PubMed Web of Science ®Google Scholar
• Neganova ME, Aleksandrova YR, Sukocheva OA, et al. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin Cancer Biol. 2022;86:805–833. doi:10.1016/j.semcancer.2022.06.011
   PubMed Web of Science ®Google Scholar
• Ezra Manicum A-L, Sargazi S, Razzaq S, et al. Nano-immunotherapeutic strategies for targeted RNA delivery: emphasizing the role of monocyte/macrophages as nanovehicles to treat glioblastoma multiforme. J Drug Deliv Sci Technol. 2022;71:103288. doi:10.1016/j.jddst.2022.103288
   Web of Science ®Google Scholar
• Wang J, Yang J, Liu K, et al. Tumor targeted cancer membrane-camouflaged ultra-small Fe nanoparticles for enhanced collaborative apoptosis and ferroptosis in glioma. Mater Today Bio. 2023;22. doi:10.1016/j.mtbio.2023.100780
   Google Scholar
• Yao Y, Ji P, Chen H, et al. Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors. Front Oncol. 2023;13:1084289.
   PubMed Web of Science ®Google Scholar
• Mansur AAP, Mansur HS, Carvalho SM. Engineered hybrid nanozyme catalyst cascade based on polysaccharide-enzyme-magnetic iron oxide nanostructures for potential application in cancer therapy. Catal Today. 2022;388–389:187–198. doi:10.1016/j.cattod.2020.06.083
   Web of Science ®Google Scholar
• Shen Z, Liu T, Li Y, et al. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors. ACS Nano. 2018;12:11355–11365. doi:10.1021/acsnano.8b06201
   PubMed Web of Science ®Google Scholar
• Hambright WS, Fonseca RS, Chen L, et al. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol. 2017;12:8–17. doi:10.1016/j.redox.2017.01.021
   PubMed Web of Science ®Google Scholar